Placebo-controlled trial of oral amantadine and zolpidem efficacy on the outcome of patients with acute severe traumatic brain injury and diffuse axonal injury
Background: A constituent of diffuse axonal injury (DAI) is supposed to be present in about 1/3 of all severe traumatic brain injury (TBI) as specified by pathologic documents. Diffuse axonal injury is categorized by extensive injury to axons in the brain. A rise in the incidences of TBI, and the li...
Saved in:
Main Authors: | sajad shafiee (Author), Saeed Ehteshami (Author), Mahmoodd Moosazadeh (Author), Saeed Aghapour (Author), Kaveh Haddadi (Author) |
---|---|
Format: | Book |
Published: |
Babol University of Medical Sciences,
2022-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diffuse Axonal Injury After Traumatic Brain Injury
by: J Gordon Millichap
Published: (2004) -
The effects of magnesium sulfate therapy after severe diffuse axonal injury
by: Zhao L, et al.
Published: (2016) -
Metabolomics reveals the effects of hydroxysafflor yellow A on neurogenesis and axon regeneration after experimental traumatic brain injury
by: En Hu, et al.
Published: (2023) -
Can amantadine cause resistant hypernatremia in the treatment of hypoxic brain injury due to cardiac arrest?
by: Burhan Sami Kalın, et al.
Published: (2022) -
Inhibition of TLR4 Signalling-Induced Inflammation Attenuates Secondary Injury after Diffuse Axonal Injury in Rats
by: Yonglin Zhao, et al.
Published: (2016)